1. Home
  2. DARE vs CPHI Comparison

DARE vs CPHI Comparison

Compare DARE & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$2.08

Market Cap

33.4M

Sector

Health Care

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$0.68

Market Cap

31.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DARE
CPHI
Founded
2015
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.4M
31.2M
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
DARE
CPHI
Price
$2.08
$0.68
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
147.6K
21.5K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,807,885.00
$4,144,268.00
Revenue This Year
$2,115.12
N/A
Revenue Next Year
$122.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$0.38
52 Week High
$9.19
$2.00

Technical Indicators

Market Signals
Indicator
DARE
CPHI
Relative Strength Index (RSI) 48.74 48.68
Support Level $1.95 $0.54
Resistance Level $2.23 $0.89
Average True Range (ATR) 0.13 0.09
MACD 0.02 -0.00
Stochastic Oscillator 54.17 37.20

Price Performance

Historical Comparison
DARE
CPHI

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: